BNBhagavathi A. Narayanan

Bhagavathi A. Narayanan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bhagavathi A. Narayanan has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Dominick Nargi

    New York University School of Medicine, Department of Environmental Medicine, Tuxedo, NY, USA

    3 shared publications
  • Narayanan K. Narayanan

    New York University School of Medicine, Department of Environmental Medicine, Tuxedo, NY, USA

    3 shared publications
  • Hye Na Kim

    New York University School of Medicine, Department of Environmental Medicine, Tuxedo, NY, USA

    2 shared publications
  • Narayanan K Narayanan

    New York University School of Medicine, Department of Environmental Medicine, Tuxedo, NY 10987, U.S.A.

    2 shared publications
  • Rajkishen Narayanan

    New York University School of Medicine, Department of Environmental Medicine, Tuxedo, NY, USA

    2 shared publications
  • Amitabha Mazumder

    1 shared publication

Latest Publications

  • Retraction
    Open Access

    Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels

    by Rajkishen Narayanan, Hye Na Kim, Narayanan K. Narayanan, Dominick Nargi, Bhagavathi Narayanan

    Following the publication of this article, which was concerned with the expression of phosphorylated epidermal growth factor receptor (pEGFR) and cyclin D1 activation independently of the expression levels of cyclo-oxygenase-2, an interested reader drew to our attention apparent anomalies associated with the western blot data shown in Fig. 2C. Following an internal investigation at the New York University School of Medicine, we were requested to produce the original film, or the scan of the image of the film, for verification. Unfortunately, we were unable to provide the original film or scanned image to disprove the allegation, since the original pEGFR image could not be found. Therefore, the Investigation Committee recommended that this article be retracted, and we are withdrawing the article in line with the request. All the authors agree to the retraction of this paper. We sincerely regret any inconvenience this has caused. [the original article was published in the International Journal of Oncology 40: 13-20, 2012; DOI: 10.3892/ijo.2011.1211].

    • 16 January 2014
      • Vol. 28  (1) , 67-73

    Characterization of multiple myeloma clonal cell expansion and stromal Wnt/β-catenin signaling in hyaluronic acid-based 3D hydrogel.

    by Narayanan K Narayanan, Bin Duan, Jonathan T Butcher, Amitabha Mazumder, Bhagavathi A Narayanan

    Emerging interest on three-dimensional (3D) cell culture models to replace two-dimensional cultures of cancer cells and their xenografts in immunocompromised animal hosts prompted us to investigate the use of new biodegradable gels to recapitulate the physiological conditions of the microenvironment of multiple myeloma (MM) cells. In the present study, for the first time, we used a new 3D model of hyaluronic acid (HA)-based hydrogels with difference in their matrix composition and stiffness. We demonstrated that hyaluronic acid (HA)-based hydrogels perfectly accommodate MM cells; confirmed by cell survival, migration, colony forming units and expression of cell adhesion proteins of the Wnt signaling pathways over a period of time. This study provides the first 3D microenvironment data that HA-based hydrogels could provide with a suitable 3D substratum for MM cells to comprehensively analyze phenotypic changes and the influence of bone marrow stromal stem cells on Wnt/β catenin signaling in response to targeted drug treatments.


    • 1 November 2012
      • Vol. 32  (11) , 4697-707

    Antagonistic effect of small-molecule inhibitors of Wnt/β-catenin in multiple myeloma.

    by Bhagavathi A Narayanan, Nicole A Doudican, Jeesun Park, Dazhong Xu, Narayanan K Narayanan, Ramanuj Dasgupta, Amitabha Mazumder

    Development and progression of multiple myeloma is dependent on the bone marrow (BM) microenvironment, and within the BM, a number of factors are secreted, including the Wnt ligands. Bone marrow stromal cells (BMSC) secrete Wnt ligands that activate Wnt signaling in multiple myeloma. The canonical Wnt pathway which is mediated through the transcriptional effector β-catenin (β-cat) is commonly de-regulated in many cancers. Cells with active β-cat-regulated transcription (CRT) are protected against apoptosis; conversely, inhibition of CRT may prevent cell proliferation. In this study, we tested the efficacy of recently described inhibitors of CRT (iCRTs; oxazole and thiazole) for their selective antagonistic effect on Wnt-β-cat response in MM cells MM.1, U266, BMSC and primary BMMC obtained from patient samples (n=16). We demonstrated that iCRTs we used, block Wnt/β-cat reporter activity, down regulate β-cat expression and inhibit cell proliferation in a dose-dependent manner with an optimal dose closer to 15 μM. Our data further indicate that iCRTs do not influence the expression of the upstream components of the Wnt pathway DKK1 at the optimal dose, suggesting that iCRTs may specifically target β-cat in MM cells. Additionally, iCRT-treatment of MM cells, co-cultured with BMSC, showed an inhibitory effect on VEGF and cell migration. This study provides the first in vitro data evaluation of newly-described iCRTs as potential Wnt-β-cat/VEGF pathway antagonists in multiple myeloma.


  • Retracted
    Open Access

    Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels

    by Bhagavathi Narayanan, Rajkishen Narayanan, Hye Na Kim, Narayanan K. Narayanan, Dominick Nargi

    Cervical cancer constitutes the second most common cancer in women. It is evident from earlier studies that epidermal growth factor (EGF) is a mitogen, in that it mimics the function of estrogen by mediating cross-talk with other oncoproteins. Although epidermal growth factor receptor (EGFR) is highly expressed in breast and ovarian tumor tissues, its regulation by the exogenous source of its ligand EGF in human papillomavirus (HPV)-associated cervical cancer remains unclear. In this study, we addressed the question of whether EGF is required for the proliferation of HPV-positive cervical cancer cells and what mechanisms are involved. To determine this, we conducted a series of studies using HPV-positive human cervical cancer cells, CaSki and HeLa, and stimulated the cells with EGF. Our findings suggest that 6 h of stimulation with 10 ng/ml of EGF is sufficient to induce cell cycle progression associated with a significant increase in DNA synthesis, EGFR, COX-2 and cyclin D1 levels. Consistently, cellular localization and Western blot analysis for p-EGFR (Try-1045) protein showed an increase after EGF stimulation. Using siRNA gene knockdown assays we have shown that cyclin D1 siRNA has a significant negative effect on EGFR and inhibit cell growth independent of COX-2 levels. In summary, our findings reveal that an exogenous EGF stimulation may enhance HPV-related cervical cancer cell proliferation by activating EGFR and cyclin D1 that is independent of COX-2 levels, suggesting that the inhibitors of EGFR and cyclin D1 may be effective against cervical cancer cell proliferation.


  • Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: Preventive effects of celecoxib

    by Narayanan K. Narayanan, Dominick Nargi, Lori Horton, Bandaru S. Reddy, Maarten C. Bosland, Bhagavathi A. Narayanan

    BACKGROUND: Prostate tissue microenvironment is susceptible to several risk factors including carcinogens, dietary factors, hormones, cytokines and growth factors that could induce chronic inflammation. Because of the difference in the serum levels and the intrinsic ability of monocytes/macrophages to cause harm, the transcriptional responses triggered by inflammatory stimuli must be controlled. Unfortunately, an in‐depth association between prostate cancer and potential mediators of inflammation has not been completely investigated.METHODS: To determine whether activated macrophage (infiltrating monocytes), iNOS and NF‐κB are primary mediators of inflammation, besides COX‐2, in prostate carcinogenesis, we examined tissue sections of rat prostate tumor induced by N‐methyl‐N‐nitrosourea (MNU) plus testosterone in a follow‐up study. We performed H&E and immunohsitochemical staining of the prostate tissue to detect specific markers of inflammation.RESULTS: We report an increase in infiltrating monocyte, iNOS, NF‐κBp65, VEGF and TNF‐α at the early and advanced stages of tumor growth in MNU plus testosterone treated rats. Monocyte infiltration was often found in the stromal and perivascular regions of the DL prostate. We conclude for the first time that prostate cancer induced by MNU plus testosterone partly involves mediators of inflammation which could trigger the process of carcinogenesis and cause loss of apoptosis. Selective COX‐2 inhibitor celecoxib at a dose of 500 mg/kg/bw administered for 52 weeks reduced infiltrating monocytes, inhibited iNOS, NF‐κB p65 expression, induced apoptosis and tumor growth inhibition.CONCLUSION: Carcinogen plus testosterone induced prostate carcinogenesis showing activation of macrophage, iNOS and NF‐κBp65 could be prevented by celecoxib or related anti‐inflammatory agents. Prostate 69: 133–141, 2009. © 2008 Wiley–Liss, Inc.